How Trump's hydroxychloroquine push became a boon for Ipca Laboratories

In March, the Food and Drug Administration lifted restrictions on Ipca Laboratories Ltd. in Mumbai to allow it to export hydroxychloroquine and a similar drug, chloroquine. That happened just days after President Donald Trump touted them as potential game changers against the virus, despite a lack of clinical evidence they’d help.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BB3oxN
via IFTTT